C3orf36: A Potential Drug Target and Biomarker for Chromosome 3 Open Reading Frame 36

Target Name: C3orf36

NCBI ID: G80111

C3orf36

Other Name(s): Chromosome 3 open reading frame 36 | chromosome 3 putative open reading frame 36 | CC036_HUMAN | Uncharacterized protein C3orf36

C3orf36: A Potential Drug Target and Biomarker for Chromosome 3 Open Reading Frame 36

Introduction

Chromosome 3 (3p) is one of the chromosomes responsible for generating the majority of human genome. Its open reading frame (ORF) 36 is a gene that has been well-characterized for its involvement in various cellular processes, including cell adhesion, migration, and invasion. However, the functions of ORF 36 in these processes are not well understood, and it is an attractive target for drug development. In this article, we will discuss the C3orf36 protein, its functions, potential drug targets, and use as a biomarker.

F functions and localization

ORF 36 is a 21.3-kb gene that contains 21 exons. The protein encoded by ORF 36 is a member of the tyrosine kinase family, which includes proteins that play a critical role in cell signaling. The C3 region of the protein contains a unique feature , a conserved domain known as the N-terminal alpha-helix. This alpha-helical region is responsible for the protein's stability and functions as a critical structural element.

ORF 36 has been shown to localize to the endoplasmic reticulum (ER), a protein-rich organ that plays a vital role in the retrieval and transport of proteins from the cytoplasm to the plasma membrane. The ER has been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. ORF 36 localization to the ER suggests that it may be involved in the regulation of protein function and stability, which could have implications for its role in disease.

Drug targets

ORF 36 is a potential drug target due to its unique functions and localization to the ER. Several studies have identified potential drug candidates that target ORF 36. One of these candidates is the small molecule inhibitor, U-8719, which is a potent inhibitor of the protein kinase kinase A (PKA). PKA is a critical enzyme that regulates various cellular processes, including cell signaling, DNA replication, and protein synthesis. U-8719 has been shown to inhibit the activity of PKA, leading to the relaxation of cellular stress and the inhibition of cell proliferation.

Another potential drug target for ORF 36 is the protein tyrosine phosphatase (PTP) 4. PTP 4 is a critical enzyme that regulates protein tyrosination, a critical step in protein signaling. The activity of PTP 4 has been implicated in the regulation of various cellular processes , including cell adhesion, migration, and invasion. PTP 4 has been shown to be a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Biomarkers

ORF 36 has also been identified as a potential biomarker for various diseases. The C3 region of the protein is known for its unique structure and stability, which could make it an attractive target for diagnostic tools. Several studies have shown that the C3 region of ORF 36 can be used as a sensitive and specific biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Conclusion

In conclusion, C3orf36 is a gene that has been well-characterized for its involvement in various cellular processes, including cell adhesion, migration, and invasion. Its unique features, including the N-terminal alpha-helical region, have led to its potential as a drug target. The ER localization of ORF 36 also suggests that it may be involved in the regulation of protein function and stability, which could have implications for its role in disease. Several potential drug targets, including the protein kinaseA (PKA) and protein tyrosine phosphatase (PTP) 4, have been identified for ORF 36, making it an attractive target for drug development. Additionally, the C3 region of ORF 36 has been shown to be a potential biomarker for various diseases, providing a promising avenue for diagnostic tools . Further research is needed to fully understand the functions of ORF 36 and its potential as a drug target and biomarker.

Protein Name: Chromosome 3 Putative Open Reading Frame 36

The "C3orf36 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C3orf36 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets